Who We Are
Shire is the leading global biotechnology company focused on serving people with rare diseases. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Haematology, Immunology, Neuroscience, Gastrointestinal/Internal Medicine and Hereditary Angioedema.
In Ireland, we have over 400 employees who come to work every day with a shared mission: to develop and deliver breakthrough therapies for people in the world affected by rare diseases and other high-need conditions and who lack effective therapies to live their lives to the fullest.
•We have the courage to lead the way
•We are agile and adaptable to meet the changing needs of stakeholders
•We deliver on our promises to all of our stakeholders
•We fearlessly innovate to address unmet patient needs
•We do the right thing
Our Therapy Areas
In Ireland, we currently offer treatments for:
• Genetic diseases
• Hereditary Angioedema (HAE)
Ireland: A Key Part of Shire’s Global Footprint
Shire’s Global HQ is based in Dublin, Ireland. We are also investing in a new state-of-the-art biologics manufacturing facility in Dunboyne, Co. Meath, currently under construction. This facility will manufacture biologic medications for Shire. It will also be the European Quality Control hub for the Shire biologics portfolio.
At Shire, we have never separated responsibility from our daily business activities, decisions and relationships. We participate in and support local Irish communities and corporate responsibility is a fundamental part of our work. Nearly 200 Dublin based employees participated in our 2017 annual global day of service. They dedicated 1,300 hours of time volunteering supporting Barretstown, Tallaght Hospital, Enable Ireland and LauraLynn.
New Roles In: • Manufacturing • Quality Assurance • Quality Control • Engineering & IT • Supply Chain Management • Environmental, Health & Safety • Process Development & Technical Services • Business Excellence • Financial Services • Human Resources
Dublin, Ireland- Group, Headquarters
Cambridge, MA- Innovation and commercial hub
Zug, Switzerland- Commercial hub
•23,000+ employees in 60+ countries
•40+ Marketed products available in more than 100 countries
•$15B+ Full Year 2017 Revenue
•Strong pipeline of innovative and novel therapies
•40 programs in our clinical pipeline
•70% of our clinical programs focused on rare diseases
•14 Manufacturing sites
•100 Plasma collection centers
•100+connections with patient advocacy groups
•Listed on both the London Stock Exchange and the NASDAQ
•Extensive manufacturing infrastructure to support therapies
•Strong commitment to running our business responsibly
At Shire, we’re committed to transforming the treatment of rare diseases and championing the fight against them.
Please enter your email address
Please enter a valid email address
Strong Knowledge in the areas of global cGMP regulations (US, EU, Japan, Canada, etc.), and quality management systems for pharmaceutical, device, biologics or biotechnology operations desired.